We are live on ! Find out more
OM icon

Outset Medical

142 hedge funds and large institutions have $2.5B invested in Outset Medical in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 60 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more call options, than puts

Call options by funds: $4.11M | Put options by funds: $841K

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

76% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 34

10% more funds holding

Funds holding: 129142 (+13)

8% more capital invested

Capital invested by funds: $2.31B → $2.5B (+$196M)

0.59% more ownership

Funds ownership: 6.71%7.3% (+0.59%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
142
Holders Change
+13
Holders Change %
+10.08%
% of All Funds
2.49%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
26
Increased
60
Reduced
34
Closed
13
Calls
$4.11M
Puts
$841K
Net Calls
+$3.27M
Net Calls Change
+$3.27M
Name Holding Trade Value Shares
Change
Change in
Stake
DM
26
Deerfield Management
New York
$19.8M
EHI
27
Eagle Health Investments
Connecticut
$16.5M +$6.67M +9,787 +79%
Charles Schwab
28
Charles Schwab
California
$14.5M +$4.63M +6,797 +54%
Lord, Abbett & Co
29
Lord, Abbett & Co
New Jersey
$10.9M +$2.28M +3,347 +29%
WP
30
Woodline Partners
California
$10.3M +$1.12M +1,650 +13%
GH
31
GAM Holding
Switzerland
$9.6M +$8.82M +12,940 New
N
32
Nuveen
North Carolina
$8.97M -$7.09M -10,411 -49%
SO
33
STRS Ohio
Ohio
$7.94M +$2.85M +4,180 +64%
Goldman Sachs
34
Goldman Sachs
New York
$6.92M +$3.28M +4,819 +107%
Neuberger Berman Group
35
Neuberger Berman Group
New York
$6.38M +$5.66M +8,301 +1,770%
CS
36
Candriam SCA
Luxembourg
$5.86M +$1.41M +2,067 +35%
Ameriprise
37
Ameriprise
Minnesota
$5.53M +$744K +1,092 +17%
BO
38
BRR OpCo
Ohio
$5.48M -$2.21M -3,245 -31%
Deutsche Bank
39
Deutsche Bank
Germany
$4.74M +$1.78M +2,613 +69%
Swiss National Bank
40
Swiss National Bank
Switzerland
$4.27M +$32K +47 +0.8%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$3.98M
TD Asset Management
42
TD Asset Management
Ontario, Canada
$3.96M +$141K +207 +4%
Voloridge Investment Management
43
Voloridge Investment Management
Florida
$3.86M +$249K +365 +8%
CM
44
Crestline Management
Texas
$3.57M +$3.28M +4,812 New
Bank of America
45
Bank of America
North Carolina
$3.19M +$2.07M +3,042 +241%
EAM
46
Eventide Asset Management
Massachusetts
$3.18M +$320K +470 +12%
GGHC
47
Gilder Gagnon Howe & Co
New York
$3.07M -$333K -489 -11%
Holocene Advisors
48
Holocene Advisors
New York
$3.07M -$683K -1,003 -20%
Ensign Peak Advisors
49
Ensign Peak Advisors
Utah
$2.86M +$277K +407 +12%
PP
50
PDT Partners
New York
$2.85M +$2.62M +3,848 New

OM Hedge Fund Activity: Q3 2021 in Review

142 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2021, worth a combined $2.5B — up 8.5% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new OM positions and 13 closed out — a net gain of 13 holders — while 60 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $45.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $100M.

  • 142 institutional investors held Outset Medical (OM) as of Q3 2021, up from 129 in Q2 2021.
  • Funds reported $2.5B of Outset Medical stock for Q3 2021, up 8.5% quarter-over-quarter.
  • 26 funds opened new Outset Medical positions in Q3 2021 and 13 closed out, a net change of +13 holders.
  • The largest Outset Medical buyer in Q3 2021 was BlackRock, an estimated $45.4M added.
  • The largest Outset Medical seller in Q3 2021 was T. Rowe Price Associates, an estimated $100M sold.

Based on aggregated 13F filings for Q3 2021.